← Back to Search

Behavioral Intervention

Virtual Reality for Eye Movement Disorders (OCNP Trial)

N/A
Recruiting
Led By Kevin E Houston, OD
Research Sponsored by Kevin Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal Group: Absence of OCNP or other neurological or neuro-ophthalmic diseases
OCNP Group: Presence of OCNP in one eye with 50% range-of-motion limitation or worse
Must not have
OCNP Group: Range of motion better than 50%
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes
Awards & highlights
No Placebo-Only Group

Summary

"This trial is looking at whether doing eye exercises using virtual reality can improve eye movement in certain conditions."

Who is the study for?
This trial is for individuals with ocular cranial nerve palsies (OCNP) affecting one eye and significantly limiting its movement, or healthy volunteers without OCNP or related conditions. Participants must have decent vision with correction, speak English fluently, and be able to give informed consent. Those with bilateral OCNP, poor visual acuity, significant vision differences between eyes, less affected range of motion, or issues that prevent VR headset use are excluded.
What is being tested?
The study tests if virtual reality eye exercises can improve the range of motion in patients with abducens palsy and internuclear ophthalmoplegia. It compares exercises done under 'head-cancelled' conditions (where head movements don't affect the VR environment) versus 'head-active' conditions.
What are the potential side effects?
While not explicitly mentioned in the provided information, potential side effects may include discomfort from wearing a VR headset for those sensitive to it and possible temporary disorientation or dizziness due to immersion in virtual reality.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any brain or eye nerve diseases.
Select...
I have OCNP in one eye with at least 50% movement limitation.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My joint movement is more than half of what is considered normal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Peak saccade amplitude
Secondary study objectives
Mean head position

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Head CancelledExperimental Treatment1 Intervention
Study tasks performed in head-cancelled conditions
Group II: NormalActive Control1 Intervention
Study tasks performed in normal conditions.

Find a Location

Who is running the clinical trial?

Kevin HoustonLead Sponsor
1 Previous Clinical Trials
11 Total Patients Enrolled
American Academy of OptometryOTHER
5 Previous Clinical Trials
253 Total Patients Enrolled
Kevin E Houston, ODPrincipal InvestigatorUniversity of Massachusetts, Worcester
2 Previous Clinical Trials
201 Total Patients Enrolled
~27 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top